The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1265-2016·Announced 2016-07-20

Pharmakon Recalls Epinephrine Injection Due to Sterility Concerns

Pharmakon Pharmaceuticals is recalling 280 vials of compounded Epinephrine injection due to a lack of assurance of sterility. The product was distributed nationwide and to specific VA/DOD facilities.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, an FDA Class II recall involving a sterile compounded drug where sterility is not assured falls under the 'Severe' category (Score 4), as it implies a risk of significant injury or infection, even if specific hospitalization reports are not detailed in the provided text snippet.

Plain-English summary

Pharmakon Pharmaceuticals, Inc. is recalling 280 units of Epinephrine 100mcg/mL injection in 0.9% Sodium Chloride 10 mL BD syringe. The recall is being conducted because of a lack of assurance of sterility for the compounded product. The affected product is identified by NDC 45183-0120-72 and includes all sterile compounded products within their expiry dates.

The recalled product was distributed nationwide as well as to specific VA/DOD facilities in California, Kentucky, Maryland, North Carolina, Oklahoma, Texas, and Virginia. The FDA has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.

Healthcare providers and patients who have received this specific compounded epinephrine product should contact Pharmakon Pharmaceuticals or their healthcare provider for further instructions. Consumers should not use the product if they have received it and should follow the guidance of their medical professionals regarding alternative treatments.

The recalled product

Product
Epinephrine 100mcg/mL injection in 0.9% Sodium Chloride 10 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0120-72
Manufacturer
Pharmakon Pharmaceuticals, Inc.
Category
Drug — Compounded Sterile Product
Hazard
Affected units
280

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Sterile Compounded Products within Expiry

Distribution

Distributed nationwide across the United States.

The notice also names 7 states specifically:

Part of a larger recall action

This product is one of 88 recalled by Pharmakon Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 88 products in this recall →

Related recalls

Same manufacturer · Pharmakon Pharmaceuticals, Inc.

See all →

Same hazard · lack of sterility

See all →

Similar recalls